[INFO] Processing sample 22
[INFO] Step 1. Single-Agent Few-shot Preparation
[INFO] Step 2. Single-Agent Final Decision
[INFO] Final decision: {0.0: "Let's analyze the question step by step. \n\nThe patient has been diagnosed with peripheral artery disease (PAD) and is experiencing intermittent claudication, which is characterized by cramping pain in the legs during physical activity due to inadequate blood flow. Cilostazol is a medication commonly used to treat this condition.\n\nCilostazol works primarily as a phosphodiesterase (PDE) inhibitor. By inhibiting phosphodiesterase type 3 (PDE3), cilostazol increases the levels of cyclic adenosine monophosphate (cAMP) in platelets and vascular smooth muscle cells. This leads to vasodilation and inhibition of platelet aggregation, which can help improve blood flow and reduce symptoms of claudication.\n\nGiven the options provided, the correct answer is:\n\n**(E) Phosphodiesterase inhibitor**."}

[INFO] API calls for this sample: 5

[INFO] Sample 22 completed successfully